Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CeriBell, Inc. (CBLL : NSDQ)

• Company Description    CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs of patients in the acute care setting. CeriBell Inc. is based in Sunnyvale, Calif. Number of Employees: 327

• Price / Volume Information    Yesterday's Closing Price: $27.13 Daily Weekly Monthly 20 Day Moving Average: 430,919 shares Shares Outstanding: 38.38 (millions) Market Capitalization: $1,041.20 (millions) Beta: 0.94 52 Week High: $28.11 52 Week Low: $10.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 13.90% 15.10% 12 Week 53.80% 50.04% Year To Date 23.71% 11.61%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 N. PASTORIA AVENUE - SUNNYVALE,CA 94085 USA ph: 800-436-0826 fax: - investors@ceribell.com https://ceribell.com

• General Corporate Information    Officers Xingjuan (Jane) Chao - President; Chief Executive Officer; and Director Rebecca Robertson - Chair of the Board of Directors Scott Blumberg - Chief Financial Officer David Foehr - Senior Vice President; Finance Juliet Tammenoms Bakker - Director Peer Information CeriBell, Inc. (BJCT) CeriBell, Inc. (CADMQ) CeriBell, Inc. (APNO) CeriBell, Inc. (UPDC) CeriBell, Inc. (IMTIQ) CeriBell, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 15678C102 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/03/26 Share - Related Items Shares Outstanding: 38.38 Most Recent Split Date: (:1) Beta: 0.94 Market Capitalization: $1,041.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.41 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.96 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 6.11% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 8.02 Price/Cash Flow: - Price / Sales: 10.21 EPS Growth vs. Year Ago Period: -34.21% vs. Previous Quarter: 1.92% Sales Growth vs. Year Ago Period: 32.54% vs. Previous Quarter: 6.05% ROE 09/30/26 - - 06/30/26 - -44.85 03/31/26 - -38.19 ROA 09/30/26 - - 06/30/26 - -35.69 03/31/26 - -30.92 Current Ratio 09/30/26 - - 06/30/26 - 9.18 03/31/26 - 10.44 Quick Ratio 09/30/26 - - 06/30/26 - 8.79 03/31/26 - 10.01 Operating Margin 09/30/26 - - 06/30/26 - -64.73 03/31/26 - -63.51 Net Margin 09/30/26 - - 06/30/26 - -64.73 03/31/26 - -63.51 Pre-Tax Margin 09/30/26 - - 06/30/26 - -64.73 03/31/26 - -63.51 Book Value 09/30/26 - - 06/30/26 - 3.38 03/31/26 - 3.72 Inventory Turnover 09/30/26 - - 06/30/26 - 1.68 03/31/26 - 1.78 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.16 03/31/26 - 0.14 Debt-to-Capital 09/30/26 - - 06/30/26 - 13.47 03/31/26 - 12.39

Powered by Zacks Investment Research ©